A Big Investor Opposes Rite Aid’s Albertsons Deal Amid Flat Pharmacy Growth

Rite Aid reported flat first quarter sales on the same day investor Highfields Capital opposed the drugstore chain’s merger with grocer Albertsons.

Read the full post on Forbes - Pharma & Healthcare